116 related articles for article (PubMed ID: 24225966)
1. Treatment of cancer-associated retinopathy with rituximab.
Dy I; Chintapatla R; Preeshagul I; Becker D
J Natl Compr Canc Netw; 2013 Nov; 11(11):1320-4. PubMed ID: 24225966
[TBL] [Abstract][Full Text] [Related]
2. Intravenous rituximab for the treatment of cancer-associated retinopathy.
Or C; Collins DR; Merkur AB; Wang Y; Chan CC; Forooghian F
Can J Ophthalmol; 2013 Apr; 48(2):e35-8. PubMed ID: 23561621
[No Abstract] [Full Text] [Related]
3. Carcinoma-associated retinopathy in a young teenager with immature teratoma of the ovary.
Turaka K; Kietz D; Krishnamurti L; Mitchell E; Scanga H; Fu VL; Sylvester C
J AAPOS; 2014 Aug; 18(4):396-8. PubMed ID: 25173906
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic pemphigus associated with CD20-positive follicular non-Hodgkin's lymphoma treated with rituximab: a third case resistant to rituximab therapy.
Hoque SR; Black MM; Cliff S
Clin Exp Dermatol; 2007 Mar; 32(2):172-5. PubMed ID: 17342796
[TBL] [Abstract][Full Text] [Related]
5. Unilateral cancer-associated retinopathy: diagnosis, serology and treatment.
Roels D; Ueno S; Talianu CD; Draganova D; Kondo M; Leroy BP
Doc Ophthalmol; 2017 Dec; 135(3):233-240. PubMed ID: 28815346
[TBL] [Abstract][Full Text] [Related]
6. Rituximab treatment for nonparaneoplastic autoimmune retinopathy.
Fox A; Jeffrey B; Hasni S; Nussenblatt R; Sen HN
Can J Ophthalmol; 2015 Dec; 50(6):e101-4. PubMed ID: 26651312
[No Abstract] [Full Text] [Related]
7. Treatment of Cancer-Associated Retinopathy: A Systematic Literature Review.
Brossard-Barbosa N; Dezard V; Margolin E
Ophthalmol Retina; 2023 Sep; 7(9):819-828. PubMed ID: 37160190
[TBL] [Abstract][Full Text] [Related]
8. Non-Hodgkin's lymphomas: understanding monoclonal antibody therapy.
Hendrix C
ONS News; 2006; 21(8 Suppl):19-20. PubMed ID: 16925135
[No Abstract] [Full Text] [Related]
9. Rituximab: current status as therapy for malignant and benign hematologic disorders.
Abdulla NE; Ninan MJ; Markowitz AB
BioDrugs; 2012 Apr; 26(2):71-82. PubMed ID: 22339395
[TBL] [Abstract][Full Text] [Related]
10. Successful rituximab treatment of refractory hemophagocytic lymphohistiocytosis and autoimmune hemolytic anemia associated with systemic lupus erythematosus.
So MW; Koo BS; Kim YJ; Kim YG; Lee CK; Yoo B
Mod Rheumatol; 2014 Sep; 24(5):855-7. PubMed ID: 24517558
[TBL] [Abstract][Full Text] [Related]
11. Cystoid macular edema from cancer-associated retinopathy.
Moyer K; DeWilde A; Law C
Optom Vis Sci; 2014 Apr; 91(4 Suppl 1):S66-70. PubMed ID: 24531653
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of type B insulin resistance with rituximab.
Manikas ED; Isaac I; Semple RK; Malek R; Führer D; Moeller LC
J Clin Endocrinol Metab; 2015 May; 100(5):1719-22. PubMed ID: 25675382
[TBL] [Abstract][Full Text] [Related]
13. Rituximab in the treatment of bullous systemic lupus erythematosus.
Alsanafi S; Kovarik C; Mermelstein AL; Werth VP
J Clin Rheumatol; 2011 Apr; 17(3):142-4. PubMed ID: 21441817
[TBL] [Abstract][Full Text] [Related]
14. TRIPLE THERAPY WITH RITUXIMAB, INTRAVENOUS IMMUNOGLOBULIN, AND INTRAVITREAL CORTICOSTEROIDS FOR MELANOMA-ASSOCIATED RETINOPATHY: TTRIIC DOES THE TRICK.
Hamdan SA; Breazzano MP; Daniels AB
Retin Cases Brief Rep; 2022 Nov; 16(6):775-778. PubMed ID: 33165302
[TBL] [Abstract][Full Text] [Related]
15. Treatment of localized oral MALT lymphoma by rituximab: a case report.
Yamagata K; Onizawa K; Kojima H; Yoshida H
Oral Maxillofac Surg; 2008 Dec; 12(4):227-30. PubMed ID: 18830723
[TBL] [Abstract][Full Text] [Related]
16. Role of ribavirin in hepatitis flare in HCV-infected patients with B cell non Hodgkin's lymphoma treated with rituximab-containing regimens.
Pellicelli AM; Zoli V
Dig Liver Dis; 2011 Jun; 43(6):501-2. PubMed ID: 21459059
[No Abstract] [Full Text] [Related]
17. Rituximab and its use in autoimmune bullous disorders.
Daniel BS; Murrell DF; Joly P
Dermatol Clin; 2011 Oct; 29(4):571-5. PubMed ID: 21925000
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for non-Hodgkin's lymphoma patients treated with chemotherapy may not predict outcome in patients treated with rituximab.
Czuczman MS; Grillo-López AJ; Alkuzweny B; Weaver R; Larocca A; McLaughlin P
Leuk Lymphoma; 2006 Sep; 47(9):1830-40. PubMed ID: 17064996
[TBL] [Abstract][Full Text] [Related]
19. A case of non-Hodgkin's lymphoma-associated pemphigus foliaceus and use of rituximab for treatment.
Prodanovic EM; Korman NJ
J Dermatolog Treat; 2008; 19(6):1-3. PubMed ID: 18720187
[TBL] [Abstract][Full Text] [Related]
20. Fatal interstitial lung disease induced by rituximab-containing chemotherapy, treatment with TNF-α antagonist and cytokine profiling: a case-report and review of the literature.
Wu Y; Jia Y; Xu J; Shuai X; Wu Y
J Clin Pharm Ther; 2013 Jun; 38(3):249-53. PubMed ID: 23506410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
